← Evidence map

ArticleNature communications2021

Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeutic.

Xuqing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

34 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33976146